XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.3
COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 13, 2024
Jun. 20, 2023
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Mar. 31, 2024
Nov. 08, 2024
Jun. 03, 2024
Feb. 23, 2023
Apr. 11, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Common stock par value     $ 0.001       $ 0.001   $ 0.001 $ 0.001      
Proceeds from warrant exercises             $ 254,000 $ 105,000          
Shares issued for service, share             30,000            
Issuance of common stock             $ 193,330          
Orocidin A/S [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Ownership percentage     5.00%       5.00%            
Noncontrolling interests     95.00%       95.00%       95.00% 95.00%  
GK Partners [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Shares issued in exercise of warrants     19,400 6,000     25,400   30,600        
Exercise price per share     $ 10.00 $ 10.00     $ 10.00   $ 10.00       $ 10.00
Proceeds from warrant exercises       $ 60,000     $ 254,000   $ 306,000        
Shares issued for service, share             30,000            
Non-cash expenses             $ 138,979            
GK Partners [Member] | Restricted Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares issued   250,000                      
Orocidin A/S [Member] | Restricted Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares issued 3,800,000                        
Common Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Shares issued for stock investment, shares           250,000 50,000,000            
Common stock par value     $ 0.001       $ 0.001            
Shares issued in exercise of warrants     19,400 6,000 8,000                
Shares issued for service, share       30,000                  
Common Stock [Member] | Orocidin A/S [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of common stock             $ 193,330            
Noncontrolling Interest [Member] | Orocidin A/S [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of common stock             9,667            
Additional Paid-in Capital [Member] | Orocidin A/S [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of common stock             $ 183,663